The effect on AurC was not described.15 Furthermore, TAS-119 and other AurA kinase inhibitors demonstrated more potent growth inhibitory effects on cancer cells with MYC oncogene amplifications and/or mutations in the Wnt/β-catenin pathway.16,17. This evidence concerns the gene MYC and cancer.